• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Devon Park BioVentures

edit

Devon Park Bioventures is a venture capital fund targeting investments in therapeutics companies and, in certain cases, medical device, diagnostic and drug discovery technology companies.

Milestones

edit

• 
  Devon Park BioVentures invested in Cara Therapeutics. (7/21/10)
  Posted 7/21/10 at 6:59pm via fiercebiotech.com
• 
  Devon Park BioVentures invested in Inotek Pharmaceuticals. (6/11/10)
  Posted 6/13/10 at 7:56pm via fiercebiotech.com
• 
  Devon Park BioVentures invested in Proteon Therapeutics. (5/28/09)
  Posted 6/17/09 at 12:20pm via proteontherapeutics.com
• 
  Devon Park BioVentures invested in Cempra . (6/2/09)
  Posted 6/17/09 at 10:44am via onbiovc.com

Investments

Videos

Sources

1. Cara rounds up $15M for post-op pain drug Read more: Cara rounds up $15M for post-op pain drug (fiercebiotech.com) [edit]
2. Inotek gathers $18M as it plots PhII trials Read more: Inotek gathers $18M as it plots PhII trials (fiercebiotech.com) [edit]
3. Cempra Pharmaceuticals, Inc.: Series C $46M (onbiovc.com) [edit]
4. Proteon Therapeutics Completes Second Closing of Equity Financing (proteontherapeutics.com) [edit]